Author: McKinley Corbley / Source: Good News Network

In a world first, Japanese neurosurgeons have implanted a Parkinson’s disease patient with “reprogrammed” stem cells – and if the treatment continues to show success, then it could be sold to other patients as early as 2023.
The devastating disease is caused by a lack of cells in the brain that produce dopamine, which is an essential neurotransmitter in the brain.
The decrease in dopamine causes trembling, a decline in motor functions, and – if the disease progresses – dementia.Scientists from Kyoto University in Japan are attempting to reverse the disease by using donated adult stem cells that have been taken from another patient so they can then “reprogram” them into embryonic cells. These reprogrammed embryonic cells, which are called induced pluripotent stem (iPS) cells, can then be developed into dopamine-producing neurons.
Some scientists have expressed…
The post First Parkinson’s Patient to Get Unique Stem Cell Treatment Could Pave the Way for Many More by 2023 appeared first on FeedBox.